Flexible design for following up positive findings.
As more population-based studies suggest associations between genetic variants and disease risk, there is a need to improve the design of follow-up studies (stage II) in independent samples to confirm evidence of association observed at the initial stage (stage I). We propose to use flexible designs developed for randomized clinical trials in the calculation of sample size for follow-up studies. We apply a bootstrap procedure to correct the effect of regression to the mean, also called "winner's curse," resulting from choosing to follow up the markers with the strongest associations. We show how the results from stage I can improve sample size calculations for stage II adaptively. Despite the adaptive use of stage I data, the proposed method maintains the nominal global type I error for final analyses on the basis of either pure replication with the stage II data only or a joint analysis using information from both stages. Simulation studies show that sample-size calculations accounting for the impact of regression to the mean with the bootstrap procedure are more appropriate than is the conventional method. We also find that, in the context of flexible design, the joint analysis is generally more powerful than the replication analysis.
Yu
Kai
K
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. yuka@mail.nih.gov
Chatterjee
Nilanjan
N
Wheeler
William
W
Li
Qizhai
Q
Wang
Sophia
S
Rothman
Nathaniel
N
Wacholder
Sholom
S
D005500:Follow-Up Studies; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics; D012107:Research Design; D018401:Sample Size
Genet Epidemiol. 2005 May;28(4):352-67
15761913
Genetics. 2005 Oct;171(2):813-23
16020784
Genet Med. 2002 Mar-Apr;4(2):45-61
11882781
Genet Epidemiol. 2007 May;31(4):288-95
17266119
Nat Genet. 2006 Feb;38(2):209-13
16415888
Lancet Oncol. 2006 Jan;7(1):27-38
16389181
Genet Epidemiol. 2003 Sep;25(2):149-57
12916023
Biometrics. 2000 Dec;56(4):1192-6
11129478
PLoS Med. 2007 Feb;4(2):e28
17326704
Biometrics. 1995 Dec;51(4):1315-24
8589224
Nature. 2007 Jun 7;447(7145):655-60
17554299
Biometrics. 2002 Mar;58(1):163-70
11890312
Cancer Res. 2006 Oct 1;66(19):9771-80
17018637
Hum Hered. 2006;62(2):84-96
17047338
Biometrics. 2001 Sep;57(3):886-91
11550941
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):197-9
17301250
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6562-6
11983868
Am J Hum Genet. 2002 Nov;71(5):1183-8
12386837
Am J Hum Genet. 1993 Mar;52(3):506-16
8447318
Hum Hered. 2003;56(1-3):56-62
14614239
Genet Epidemiol. 2004 Dec;27(4):401-14
15543639
Biometrics. 1994 Dec;50(4):1029-41
7786985
Biometrics. 2004 Sep;60(3):589-97
15339280
Am J Hum Genet. 2001 Dec;69(6):1357-69
11593451
Am J Hum Genet. 2007 Apr;80(4):605-15
17357068
Am J Hum Genet. 2002 Mar;70(3):575-85
11836648